Drugs / BNT-152 MRNA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04710043 | Jun 2021 → Sep 2025 | cancer | BioNTech SE | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BNT-152 MRNA | ChEMBL registry synonym — accepted as the source's own label CHEMBL5315013 ↗ |
| Known as | BNT152 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04710043 ↗ |